ATE412892T1 - Enzymtest zur bestimmung von krankheitsrisiken in verbindung mit der anwesenheit von sialidase oder prolidase aktivität in körperflüssigkeit von frauen - Google Patents
Enzymtest zur bestimmung von krankheitsrisiken in verbindung mit der anwesenheit von sialidase oder prolidase aktivität in körperflüssigkeit von frauenInfo
- Publication number
- ATE412892T1 ATE412892T1 AT01912101T AT01912101T ATE412892T1 AT E412892 T1 ATE412892 T1 AT E412892T1 AT 01912101 T AT01912101 T AT 01912101T AT 01912101 T AT01912101 T AT 01912101T AT E412892 T1 ATE412892 T1 AT E412892T1
- Authority
- AT
- Austria
- Prior art keywords
- sialidase
- women
- body fluid
- activity
- prolidase activity
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 6
- 102000005348 Neuraminidase Human genes 0.000 title abstract 5
- 108010006232 Neuraminidase Proteins 0.000 title abstract 5
- 102100039662 Xaa-Pro dipeptidase Human genes 0.000 title abstract 5
- 108010066823 proline dipeptidase Proteins 0.000 title abstract 5
- 210000001124 body fluid Anatomy 0.000 title abstract 3
- 239000010839 body fluid Substances 0.000 title abstract 3
- 108090000790 Enzymes Proteins 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 230000007170 pathology Effects 0.000 abstract 2
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000011422 pharmacological therapy Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2001/000069 WO2002065122A1 (en) | 2001-02-15 | 2001-02-15 | Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412892T1 true ATE412892T1 (de) | 2008-11-15 |
Family
ID=11133622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01912101T ATE412892T1 (de) | 2001-02-15 | 2001-02-15 | Enzymtest zur bestimmung von krankheitsrisiken in verbindung mit der anwesenheit von sialidase oder prolidase aktivität in körperflüssigkeit von frauen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040219617A1 (de) |
| EP (1) | EP1360484B1 (de) |
| CN (1) | CN1503908A (de) |
| AT (1) | ATE412892T1 (de) |
| DE (1) | DE60136388D1 (de) |
| WO (1) | WO2002065122A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60107284T2 (de) * | 2001-02-15 | 2005-12-29 | Unibio S.R.L. | Diagnostisches verfahren zur erkennung von bakterieller vaginose auf basis der bestimmung von anti-gardnerella-vaginalis-gvh-toxin antikörpern |
| EP1576181B1 (de) * | 2002-01-31 | 2013-08-14 | Systagenix Wound Management IP Co. BV. | Verfahren zum nachweis pathogenenbakterien in wunden |
| US20050095660A1 (en) * | 2003-10-31 | 2005-05-05 | Unibio, S.R.I. | Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women |
| AU2006268140A1 (en) * | 2005-07-13 | 2007-01-18 | Expressive Constructs, Inc. | Substrates, sensors, and methods for assessing conditions in females |
| GB0608838D0 (en) * | 2006-05-04 | 2006-06-14 | Novartis Ag | Organic compounds |
| US7591978B2 (en) | 2006-08-10 | 2009-09-22 | Inverness Medical Switzerland Gmbh | Solid phase test device for sialidase assay |
| FR2955592B1 (fr) | 2010-01-27 | 2016-04-15 | Millipore Corp | Milieu de culture pour la detection de microorganismes par fluorescence alliant un substrat fluorogene et un fluorophore sensible au ph |
| CN105695557B (zh) * | 2016-03-16 | 2019-09-24 | 四川大学华西第二医院 | 检测体外精子获能液中的唾液酸酶的试剂盒的使用方法 |
| CN105779568B (zh) * | 2016-03-16 | 2019-09-24 | 四川大学华西第二医院 | 一种体外获能后精子质量评估的试剂盒及其使用方法 |
| CN105671126B (zh) * | 2016-03-16 | 2019-09-24 | 四川大学华西第二医院 | 检测精子中唾液酸酶的试剂盒的使用方法 |
| CN106319028B (zh) * | 2016-11-15 | 2020-07-24 | 郑州安图生物工程股份有限公司 | 用于检测解脲支原体和人型支原体的试剂盒 |
| CN109991221A (zh) * | 2019-03-29 | 2019-07-09 | 迪瑞医疗科技股份有限公司 | 一种脯氨酸氨基肽酶检测试纸的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571684A (en) * | 1994-11-07 | 1996-11-05 | Litmus Concepts, Inc. | Assay for proline iminopeptidase and other hydrolytic activities |
| ES2253833T3 (es) * | 1998-10-27 | 2006-06-01 | Ibbex, Inc. C/O Gryphus Diagnostics, L.L.C. | Sustratos cromogenicos de sialidasa y procedimientos para la preparacion y la utilizacion de los mismos. |
| GB9906140D0 (en) * | 1999-03-17 | 1999-05-12 | Univ Bristol | A diagnostic test |
| US20050095660A1 (en) * | 2003-10-31 | 2005-05-05 | Unibio, S.R.I. | Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women |
-
2001
- 2001-02-15 AT AT01912101T patent/ATE412892T1/de not_active IP Right Cessation
- 2001-02-15 DE DE60136388T patent/DE60136388D1/de not_active Expired - Fee Related
- 2001-02-15 WO PCT/IT2001/000069 patent/WO2002065122A1/en not_active Ceased
- 2001-02-15 US US10/467,357 patent/US20040219617A1/en not_active Abandoned
- 2001-02-15 CN CNA018226523A patent/CN1503908A/zh active Pending
- 2001-02-15 EP EP01912101A patent/EP1360484B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1360484A1 (de) | 2003-11-12 |
| WO2002065122A1 (en) | 2002-08-22 |
| EP1360484B1 (de) | 2008-10-29 |
| CN1503908A (zh) | 2004-06-09 |
| US20040219617A1 (en) | 2004-11-04 |
| DE60136388D1 (de) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE412892T1 (de) | Enzymtest zur bestimmung von krankheitsrisiken in verbindung mit der anwesenheit von sialidase oder prolidase aktivität in körperflüssigkeit von frauen | |
| DE60230320D1 (de) | Diagnose von einer klinischen infektion einer wunde | |
| ATE429640T1 (de) | Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort | |
| DE69923183D1 (de) | Gerät zur feststellung von hautimpedanzveränderungen | |
| DK95792D0 (da) | Sensor til non-invasiv, in vivo bestemmelse af en analyt og blodgennemstroemning | |
| DE59912716D1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
| AU2392692A (en) | Method and kit for measuring endogenous cytokines | |
| ATE347697T1 (de) | Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten | |
| ATE529743T1 (de) | Verfahren und kits zur tumorigenizitätsdiagnose | |
| DE60237448D1 (de) | Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten | |
| GR1004071B (el) | Συγχρονη αναλυση δειγματων αιματος και εκτιμηση περιεχομενου αιματος (αιμοσφαιρινη). | |
| DE69016858D1 (de) | Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma. | |
| CN108333362A (zh) | 一种人体疲劳测定方法 | |
| WO2002103059A3 (en) | Innate immunity markers for rapid diagnosis of infectious diseases | |
| SE9800629D0 (sv) | Mätanordning, särskilt för blodsockerbestämning | |
| DE69426028D1 (de) | Reagenz für die enzymatische Bestimmung des Bikarbonatgehalts in Blutserum | |
| ATE499611T1 (de) | Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i | |
| WO2003056341A3 (de) | Verfahren zur diagnose von brustkrebserkrankungen, zugehörige peptide und deren verwendungen | |
| WO1998046993A3 (en) | Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor | |
| ATE389029T1 (de) | Protease assay zur kontrolle medikamentöser therapie | |
| SE9403953D0 (sv) | Sequence-based diagnosis | |
| SE0102220D0 (sv) | Method for estimation of the amount of specific cell types | |
| WO2004017905A3 (en) | Method and apparatus for noninvasively evaluating endothelial function | |
| IT1197891B (it) | Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti | |
| ATE386269T1 (de) | Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |